04-05-2018, 05:22 AM
04-05-2018, 12:24 PM
Test of choice “initial evaluation” -> FNA. Often combo US “guidance” for better Dx utility. 1st advantage of to lower the rate of inadequate sampling & also ↓ sample/error -> reduce both nondx & FN rates cytology.
FNA 1st choice. but in case u got combo/FNA + US then that would be a better choice to go with.
IN CLINCIAL practice, you get norm TFT’s back, I’m assuming u understand u do scan if RAIU scan -> “HOT” then -> ASX -> observe and if Sx/+ -> TMG or toxic adenoma. If “COLD” -> FNA -> solid -> then cytology’s (assuming cytolgoy wise steps) & if cystic -> observe it.
FA got it wrong.
FNA 1st choice. but in case u got combo/FNA + US then that would be a better choice to go with.
IN CLINCIAL practice, you get norm TFT’s back, I’m assuming u understand u do scan if RAIU scan -> “HOT” then -> ASX -> observe and if Sx/+ -> TMG or toxic adenoma. If “COLD” -> FNA -> solid -> then cytology’s (assuming cytolgoy wise steps) & if cystic -> observe it.
FA got it wrong.
04-07-2018, 06:57 PM
2015 American Thyroid Association Management
Guidelines for Adult Patients with Thyroid Nodules
and Differentiated Thyroid Cancer:
US first, then FNA
https://www.liebertpub.com/doi/pdf/10.10....2015.0020
Guidelines for Adult Patients with Thyroid Nodules
and Differentiated Thyroid Cancer:
US first, then FNA
https://www.liebertpub.com/doi/pdf/10.10....2015.0020